SMX (Security Matters) Public Limited Company is a Dublin-based, Nasdaq-listed micro-cap that sells molecular marker, reader, and digital platform technology for product authentication, supply-chain traceability, and material circularity programs. It generates no meaningful revenue and carries a market value of roughly $2.7 million.
On Wednesday, Nov. 18, the shares were trading at $2.985, down 13.83% from the prior session's close of $3.47, a decline of $0.48. The direction was unambiguously negative, and the move leaves the stock a fraction above the $2.90 intraday low it touched a day earlier. No verified news or fundamental development was published before or during the session that explains the size of the drop.
No verified news or fundamental catalyst found for today's session specifically. The drivers instead trace to a sequence of disclosable corporate events that reshaped the share structure over the past two weeks.
On Nov. 4, the company set a 2.8-for-1 reverse stock split effective Nov. 9, cutting outstanding shares from about 2.5 million to 897,717. The restructuring briefly ignited a violent squeeze: the stock jumped from $4.93 on Nov. 6 to $19.25 on Nov. 10, before collapsing 42% and 57% in the following two sessions. That rally has now fully reversed.
The more durable weight is issuance. A resale prospectus supplement covers up to 9,076,535 ordinary shares tied to a standby equity purchase agreement that gives the company access to as much as $250 million in equity financing. Against fewer than 900,000 shares outstanding, that pipeline represents enormous potential dilution, and each drawdown places stock in the market. On Nov. 12, the company then granted roughly 622,000 restricted stock units — nearly 70% of the current share count — with 75% vesting immediately, after expanding its incentive plan's authorized shares.
With a float near 300,000 shares, order flow that would be routine in a larger name moves the price by double digits. The pattern is consistent with speculative, momentum-driven trading in a thinly traded micro-cap trading well below every major moving average.
Volume has been far above normal for weeks. The stock traded 6.26 million shares on Nov. 17 against a three-month average of roughly 854,000, while the ten-day average has climbed above 4.8 million — evidence of a speculative crowd rather than institutional accumulation. Turnover on that scale in a float this small produces outsized price swings in both directions.
The move diverged from broad market conditions and showed no sector-wide read-through; this was an isolated, single-name event driven by capital structure. Technically, the shares are far beneath their 50-day and 200-day moving averages, and the $2.90 level from Nov. 17 is the only nearby reference point. A close below it would mark a fresh 52-week low, extending a twelve-month decline of more than 99%.
The score runs from 0, meaning no meaningful news and a price move normal for the stock, to 100, meaning transformative news and an extreme, rare move. SMX scores 19 out of 100.
Verified news is thin: the reverse split, the resale registration, and the November restricted stock unit grants are real and dilutive relative to a company this small, but they are routine corporate-housekeeping filings rather than new fundamental developments. The price move was also unremarkable by the stock's own standards. Today's 13.83% decline is only about 1.1 times the average absolute daily move of roughly 12.2% over the past 60 sessions, and at least 12 sessions in that window produced equal or larger moves. Weak news plus a typical-sized move for this name yields a low score.
The next scheduled checkpoint is the annual general meeting on Nov. 27, where shareholders vote on director re-elections, amendments reflecting the company's repeated reverse splits since 2023, and a capital reduction intended to create distributable reserves. Any further drawdowns under the equity purchase facility would add shares into an already saturated market.
Financial results are not expected before mid-March 2027, and the company carries no published analyst coverage or consensus estimates, leaving investors without external benchmarks. Watch the $2.90 level, the pace of new share issuance, and whether volume normalizes; until then, the path of least resistance remains tied to supply rather than to operating news. The principal risks are continued dilution, listing-compliance pressure, and the absence of revenue to support valuation.
Tickeron's Trending AI Robots page highlights a curated selection drawn from hundreds of AI trading bots that cover thousands of tickers. Rather than listing every strategy, it surfaces only those bots performing strongest under current market conditions. The bots differ widely by strategy, timeframe, performance metrics, and the symbols they trade, letting users compare approaches side by side. For readers tracking volatile micro-caps like this one, it offers a structured way to see how automated strategies are positioned right now.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SMX declined for three days, in 356 of 373 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The 10-day RSI Indicator for SMX moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 19 similar instances where the indicator moved out of overbought territory. In 8 of the 19 cases, the stock moved lower in the following days. This puts the odds of a move lower at 42%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SMX as a result. In 58 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The Aroon Indicator for SMX entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for SMX just turned positive on October 15, 2026. Looking at past instances where SMX's MACD turned positive, the stock continued to rise in 19 of 33 cases over the following month. The odds of a continued upward trend are 58%.
SMX moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +290.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where SMX advanced for three days, in 82 of 126 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
SMX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.043) is normal, around the industry mean (5.887). P/E Ratio (-0.009) is within average values for comparable stocks, (33.618). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.946). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (9.907).
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. SMX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SMX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry OfficeEquipmentSupplies